India’s Manipal Health Enterprises Ltd. has reportedly reduced its initial public offering (IPO) valuation to approximately ₹80,000 crore, down from the previously estimated range of $10 billion to $12 billion. This adjustment comes as the company prepares to launch its IPO, expected in the week starting July 27, 2026, according to sources familiar with the matter. The planned offering aims to raise up to ₹11,000 crore, making it the largest IPO in India for 2026 thus far, surpassing SBI Funds' $1 billion IPO this week.
Market Conditions
The revised valuation reflects a cautious investor sentiment amid ongoing tensions in the Middle East, which have introduced volatility into global financial markets. Sources indicated that discussions regarding the IPO's details, including its final valuation and timing, are still in progress. A representative from Manipal Hospitals did not respond to requests for comment on the matter.
IPO Structure
The IPO will consist of a fresh issue of shares worth about ₹8,000 crore, alongside an offer for sale of approximately 43.23 million shares by existing shareholders, including TPG Inc. The proceeds from the primary issue are intended for debt repayment, capital expenditures, and supporting the company’s expansion plans, as outlined in the draft prospectus. Manipal Health is collaborating with several financial institutions, including Kotak Mahindra Capital Co., Axis Capital Ltd., and the Indian branches of Goldman Sachs Group Inc., JPMorgan Chase & Co., Jefferies Financial Group Inc., UBS Group AG, and DBS Bank Ltd. on the offering.
The adjustment in valuation could influence investor interest in the IPO, particularly in the healthcare sector, which may face scrutiny given current market conditions. A lower valuation might attract more cautious investors, potentially impacting share pricing upon listing. Watch for further updates on the IPO details as the launch date approaches.